1 Day
Source:
النهار أونلاين
Germany Partners on Pulmonary Fibrosis Treatment
Algerian Sidall Company, in collaboration with the German Boehringer Ingelheim, oversaw the signing of an agreement to localize the manufacturing and production of an innovative treatment for pulmonary fibrosis in the Algerian market. The goal of the agreement is to support local capabilities and strengthen health sovereignty, with production beginning at the Haraouach facility according to the latest standards, to provide a treatment that slows disease progression and improves patients' quality of life.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)